US
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Literature - Publication Review
Research and characterization of bispecific antibodies for cancer immunotherapies
Literature review on BsAb therapeutic research and discovery
Bispecific antibodies (BsAbs) are a rapidly growing area of immunotherapy, garnering attention as a next-generation strategy for treating cancer. BsAb characterization is essential for design, development, efficacy, and safety assessment.
In this literature review, we describe several functional approaches to characterize novel BsAbs targeting immune checkpoints and the tumor necrosis factor (TNF) superfamily, with easy-to-use immunoassays.
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
Research and characterization of bispecific antibodies for cancer immunotherapies